Watch this webinar to discover:

Early protocol design decisions carry significant operational consequences for clinical supply strategy and randomization and trial supply management (RTSM) performance. Many issues that emerge mid-study originate in assumptions, definitions or design choices made long before enrolment begins. This webinar brings together specialists from Converge, 4G Clinical and a sponsor representative to examine these early decisions from multiple operational perspectives, offering the type of insight typically gained only through direct collaboration with experienced partners.

Using protocol scenario as the anchor, the discussion will explore how design choices influence forecasting approaches, kit architecture, expiry strategy, pooling models, resupply logic and broader RTSM behavior. By analyzing these factors collectively, the panel will reveal how different stakeholders interpret the same protocol, where misalignment most often occurs and how early clarity can prevent downstream complications.

The conversation is designed to share expert thinking rather than case studies or product walk-throughs. The focus is on the practical considerations that senior supply professionals, RTSM specialists and study teams consistently prioritize when evaluating a new protocol. Attendees will gain a clearer sense of which elements of the protocol deserve deeper operational scrutiny, how to avoid assumptions that introduce risk and the types of questions that promote stronger cross-functional alignment from the outset.

The session will close with a brief look forward at how emerging technologies, including AI-enabled tools, may influence future protocol development and supply planning. This adds a measured horizon-scanning perspective, complementing the panel’s practical guidance.